All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
  ÂCidnavir Injection
Prescription Required
Salt Composition : Cidofovir
Manufacturer : EMCURE PHARMACEUTICALS LTD
Origin of Medicine : India
1 Vial(s)
PAP Information : Â Â Buy 20, Get 1 Free. Contact us for latest updates.
Program Overview: EMCURE PHARMACEUTICALS LTD Patient Assistance Program (PAP) is dedicated to helping patients in need of Cidnavir injections. The program aims to provide eligible patients with access to the medication at a more affordable cost.
Program Benefits: Purchase 20 vials of Cidnavir injection, and you will receive one free vial. Therefore, if eligible, you will have to pay only Rs.8,84,000 for 21 vials, which is Rs.42,095 per vial.
With MrMed's MRP discount of Rs. 11,025 per vial and Emcure’s PAP program, the overall savings are over 3 lakhs per purchase. Â
Contact us for the latest updates on this exclusive offer.Â
Eligibility Criteria: To qualify for the Cidnavir Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for Cidofovir from a medical infectious disease specialist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.
Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].
Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by emcure can avail of it without having to purchase the medication from MrMed.
Patient Assistance Programs
Program Overview: EMCURE PHARMACEUTICALS LTD Patient Assistance Program (PAP) is dedicated to helping patients in need of Cidnavir injections. The program aims to provide eligible patients with access to the medication at a more affordable cost.
Program Benefits: Purchase 20 vials of Cidnavir injection, and you will receive one free vial. Therefore, if eligible, you will have to pay only Rs.8,84,000 for 21 vials, which is Rs.42,095 per vial.
With MrMed's MRP discount of Rs. 11,025 per vial and Emcure’s PAP program, the overall savings are over 3 lakhs per purchase. Â
Contact us for the latest updates on this exclusive offer.Â
Eligibility Criteria: To qualify for the Cidnavir Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for Cidofovir from a medical infectious disease specialist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.
Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].
Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by emcure can avail of it without having to purchase the medication from MrMed.
Introduction to Cidnavir Injection
Cidnavir Injection is an antiviral drug that belongs to the category of purine nucleosides, containing the active ingredient Cidofovir. It is used to treat Cytomegalovirus (CMV) retinitis in patients with AIDS. It is a serious opportunistic infection that can occur in individuals with AIDS. It affects the retina of the eye and can lead to vision impairment if left untreated.
Â
Contact your physician immediately if you experience allergies to this drug and its ingredients. If you get pain, redness, itching of the eye, or changes in your vision, tell your doctor promptly. This drug should be cautiously used if you have diabetes mellitus because there may be an increased risk of developing low eye pressure (ocular hypotony). You will need to have your eyes and blood counts tested regularly.
Â
Discuss the contraceptive options with your doctor before starting this treatment if there is a possibility that you may become pregnant. Women should use reliable birth control during treatment and at least six months after the last dose. Avoid breastfeeding your baby while on the medicine, as it is unknown if the Cidnavir injection passes into the breast milk. Talk to your doctor if you take any other medications before using over-the-counter or herbal products. Your doctor will evaluate the risk of interaction with this medication.
Uses of Cidnavir Injection
- Treatment for Cytomegalovirus (CMV) retinitis in patients with AIDS
Therapeutic Effects of Cidnavir Injection
Cidnavir injection inhibits viral DNA polymerase, which produces new viral RNA and DNA in infected cells. It is taken up intracellularly by active transport or fluid-phase endocytosis to exert its antiviral actions.
Interaction of Cidnavir Injection with other drugs
Inform your healthcare provider about all your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Cidnavir injection and reduce effectiveness by causing undesirable side effects.
More Information about Cidnavir Injection
- Store Cidnavir injection vials at refrigerated temperature (2°C to 8°C)
- Do not freeze.
- Keep it out of reach from children.
How to consume Cidnavir Injection
The medicine will be administered to you by a healthcare professional in a hospital setting. It is usually administered as an intravenous injection into a vein. Your doctor will decide the dose, route of administration, and frequency based on your disease condition and other factors.
Safety Advices for Cidnavir Injection
 Â
Pregnancy
 ÂIt is unknown whether Cidnavir injection can cause fetal harm to the fetus when administered to pregnant women. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.
 Â
Breast Feeding
 ÂIt is unknown if Cidnavir injection passes into the breast milk or if it will harm your baby. Please consult your doctor before breastfeeding.Â
 Â
Lungs
 ÂIt is unknown whether Cidnavir injection can be used for patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
 Â
Liver
 ÂInform your physician if you have liver problems before initiating the treatment with Cidnavir injection.
 Â
Alcohol
 ÂIt is unknown whether Cidnavir injection can be used for patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
 Â
Driving
 ÂCidnavir injection may cause short-term side effects such as fatigue or weakness. Avoid driving and operating heavy machinery.
Side Effects of Cidnavir Injection
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Serious
- Kidney damage
Common
- Nausea, vomiting
- Headache
- Hair loss
- Weakness
- Fever, chills
- Difficulty in breathing
- Diarrhea
- Inflammation of the eye, reduced pressure in the eyes
Word of Advice
Drink plenty of water with this antiviral medicine, which helps prevent dehydration and kidney damage. While receiving Cidnavir injection and for three months afterward, males should use (condom) barrier birth control techniques. Sodium is present in this drug. If you follow a salt-restricted diet, seek a physician's guidance.
FAQs
Q 1. What are the uses of Cidnavir injection?
Cidnavir injection is used to treat CMV retinitis, an eye infection that affects AIDS patients. Cytomegalovirus causes an eye infection known as CMV retinitis (CMV).
Q 2. What are the common side effects of Cidnavir injection?
Nausea, vomiting, headache, hair loss, weakness, fever, chills, difficulty breathing, diarrhea, inflammation of the eye, and reduced pressure in the eyes are the common side effects of Cidnavir injection.
Q 3. What is the mechanism of action of Cidnavir injection?
Cidnavir injection inhibits viral DNA polymerase, which produces new viral RNA and DNA in infected cells. It is taken up intracellularly by active transport or fluid-phase endocytosis to exert its antiviral actions.
Q 4. What is the brand name of Cidnavir injection?
Vistide is the brand name of Cidnavir injection, a topical or injectable antiviral medication used for CMV retinitis (a retina infection of the eye) in people with AIDS.
Q 5. Is Cidnavir injection safe for pregnancy?
No, Cidnavir injection is not safe during pregnancy. Consult your doctor if you are pregnant, breastfeeding, or planning to have a baby. Women should use a reliable method of birth control during treatment and at least six months after the last dose.
Q 6. Can a diabetic patient take Cidnavir injection?
Cidnavir injection should be used cautiously in diabetic patients due to the potential increased risk of developing low pressure in the eye (ocular hypotony).
Q 7. What is Cidnavir injection's class?
Cidnavir injection belongs to a class of medications called antivirals.
Q 8. What are the available Cidnavir injection doses?
The recommended dose of Cidnavir injection is 5 mg/kg body weight, administered once weekly for two consecutive weeks. It will be given intravenously by a qualified healthcare professional at a constant rate for over 1 hour.
Fact Box of Cidnavir Injection
Molecule name: Cidofovir | Therapeutic class: Antiviral |
Pharmacological class:Â Nucleotide analogue reverse transcriptase inhibitor (NRTI) | Indications: Treatment for Cytomegalovirus (CMV) retinitis in patients with AIDS |
References
- Tillomed Laboratories Limited, Electronic medicines compendium (EMC), [ Revised on February 2022] [ Accessed on 10th May 2023], https://www.medicines.org.uk/emc/files/pil.11151.pdf
- Food and Drug Administration. Cidofovir. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/1999/020638s003lbl.pdf [ Accessed on 10th May 2023].
- Vistide: EPAR -product information - european medicines agency. Available at: https://www.ema.europa.eu/en/documents/product-information/vistide-epar-product-information_en.pdf [ Accessed on 10th May 2023].
- Goodman & Gilman's, The Pharmacological Basis of Therapeutics, Antiviral agents (nonretroviral), 12th edition, 2011, 1600-1601.
- KD Tripathi, Essentials of Medical Pharmacology, Antiviral drugs, 7th edition, 2013, 798-802.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.